Psychosis affects nearly 50% of patients with Parkinson’s disease (PD). It is a major therapeutic challenge, as a balance needs to be found between the PD medications that can exacerbate psychotic symptoms and the antipsychotics that may worsen motor function. Focusing on the most common side effects of PD medications, namely visual hallucinations and delusions, this highly readable handbook will increase readers’ awareness of: • the various presentations of psychosis in PD • modifiable risk factors • prescribing that balances the benefits and potential harms. Detailed case studies and evidence-based guidance for practical application make 'Fast Facts: Psychosis in Parkinson’s Disease' an invaluable resource for all healthcare professionals responsible for the outpatient care of patients with PD, including neurologists, psychiatrists, geriatricians, psychiatric nurse practitioners, specialist PD nurses and primary care providers.

Effective multidisciplinary management and support of patients with Parkinson’s disease can have an enormously positive effect on quality of life, and that’s the focus throughout this refreshingly readable resource. With the patient’s experience at its core, 'Fast Facts: Parkinson’s Disease' takes the non-specialist through the patient’s Parkinson’s journey from unexplained prodromal symptoms to palliative support. It includes: • the latest diagnostic techniques • effective management strategies for both motor and non-motor complications • neurosurgical treatments and candidate assessment • the latest pharmacological developments • multidisciplinary palliative care. This practical handbook reflects the importance of addressing non-motor symptoms, the need for multidisciplinary care and the use of tools that empower patients. It is a truly useful and unique resource that will help all doctors, nurses and therapists to provide the best possible care for their patients with Parkinson’s disease or related disorders.

Patients with Parkinson's disease (PD) are known to suffer from motor symptoms of the disease, but they also experience non-motor symptoms (NMS) that are often present before diagnosis or that inevitably emerge with disease progression. The motor symptoms of Parkinson's disease have been extensively researched, and effective clinical tools for their assessment and treatment have been developed and are readily available. In contrast, researchers have only recently begun to focus on the NMS of Parkinson's Disease, which are poorly recognized and inadequately treated by clinicians. The NMS of PD have a significant impact on patient quality of life and mortality and include neuropsychiatric, sleep-related, autonomic, gastrointestinal, and sensory symptoms. While some NMS can be improved with currently available treatments, others may be more refractory and will require research into novel (non-dopaminergic) drug therapies for the future. Edited by members of the UK Parkinson's Disease Non-Motor Group (PD-NMG) and with contributions from international experts, this new edition summarizes the current understanding of NMS symptoms in Parkinson's disease and points the way towards future research.

This comprehensive reference provides a detailed overview of current concepts regarding the cause of Parkinson's disease-emphasizing the issues involved in the design, implementation, and analysis of epidemiological studies of parkinsonism.

The new edition of this popular handbook has been thoroughly updated to include the latest data concerning treatment of first-episode patients. Drawing from their experience, the authors discuss the presentation and assessment of the first psychotic episode and review the appropriate use of antipsychotic agents and psychosocial approaches in effective management.

Filling a noticeable gap in the market for a new text solely focused on Dementia with Lewy Bodies, this book discusses cutting-edge topics covering the condition from diagnosis to management, as well as what is known about the neurobiological changes involved. With huge progress having been made over the last decade in terms of the disorder

Although dopaminergic medication is the most effective treatment for patients with Parkinson’s disease (PD), its long-term use is associated with debilitating motor fluctuations. Patients may not spontaneously seek assistance when fluctuations develop, so strategies need to be put in place to identify and alleviate motor dysfunction. This concise resource will increase readers’ awareness of: • the different types of motor fluctuation, why they occur and how to recognize them • the drugs that can be added to levodopa to reduce fluctuations • advanced and emerging therapies that will help to improve outcomes. No two patients with PD are alike in their disease progression or response to treatment. This 'Fast Facts' title provides the information healthcare professionals need to provide effective individualized care that will improve their patients’ quality of life.